Venture Capital

HGCO19 vaccine candidate: Gennova starts enrolment for Phase 1/2 human clinical trials


New Delhi, Apr 13 (PTI) Gennova has initiated the enrolment of volunteers for Phase 1/2 clinical trials for its mRNA vaccine candidate HGCO19, the …

Read more

Show More

Related Articles

Back to top button